RPCEC00000106已完成2 期
Human Recombinant Epidermal Growth Factor in patients with venous ulcers.
Center for Genetic Engineering and Biotechnology (CIGB), in Havana.0 个研究点目标入组 50 人开始时间: 2011年5月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 /A (No limit)（—）
- 性别
- All
入选标准
- •1.Informed consent of patient. 2.Age major than 18 years old. 3.Diagnosis of an only venous ulcer in lower limbs, not infected, up to 1 cm2 and minor than 10 cm2.
排除标准
- •1.Diabetes mellitus, Sickle Cell anemia. 2.Cancer (except the basal cell carcinoma and the cervix cancer in situ after surgery and complete cured). 3.Metabolic disease (liver disease, renal disease, pancreatic diseases, colagenosis) Mild o serious anemia (Hb = 11 g/L for women y 12 g/L for men). 4.Severely disabled (caquexia, critical patients, life-threatening diseases). 5.Uncontrolled Hypertension due to clinical examination. 6.Peripheral arterial chronic diseases referred by patient and confirm bay clinical examination. 7.Patients treated with steroids in the last 3 months. 8.Patients treated with EGF in the last 30 days. 9.Serious psychiatric disorder and other disease that limit informed consent. 10.Pregnancy or nursery.
研究者
相似试验
已完成
2 期
EGFpeeling IAcne scarring, melasm, or other injuries that require chemical peeling.RPCEC00000107Center for Genetic Engineering and Biotechnology (CIGB), in Havana.30
已完成
1 期
A Phase 1 Study of Epidermal Growth Factor Receptor (EGFR) Targeted, PaclitaxelLoaded EnGeneIC Delivery Vehicles (Erbitux®EDVsPac) in Patients with Advanced SolidTumoursAdvanced Solid TumoursCancer - Other cancer typesACTRN12609000672257EnGeneIC Pty Ltd32
已完成
2 期
The effectiveness of an epidermal growth factor containing cream on postinflammatory hyperpigmentation after 1064 nm Q-switched Nd:YAG laser treatment of Hori nevus in AsiansPostinflammatory hyperpigmentationParticipants with symmetrical Hori nevusEpidermal growth factor1,064-nm Q-switched Nd:YAG laserHori nevusTCTR20210301001Division of Dermatology Ramathibodi hospital30
已完成
不适用
The effects of epidermal growth factor receptor inhibition on pulmonary arterial hypertension associated with systemic sclerosisSclerosis-associated Pulmonary Arterial Hypertension (SScPAH)Circulatory SystemPulmonary Arterial HypertensionISRCTN75611179VU University Medical Centre (The Netherlands)20
招募中
不适用
ung Cancer Epidermal Growth Factor (EGFR) Gene Mutation Testing in New Zealandung cancerCancer - Lung - Non small cellLung cancerACTRN12615000998549Auckland UniServices Ltd2,000